Skip to main content

Advertisement

SpringerLink
Log in

Peter Riederer “70th birthday” Neurobiological foundations of modern addiction treatment

  • Biological Psychiatry - Review article
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Abstract

Alcohol dependence is caused by complex interactions of multiple susceptibility genes with little effect each and environmental factors. Candidate genes influence metabolism of alcohol, such as alcohol dehydrogenase and aldehyde dehydrogenase, and modulatory transmitter systems, such as the dopaminergic, serotonergic, acetylcholinergic, gamma-aminobutyric acidergic, and various neuropeptidergic systems. Dysfunctional behavioral choices, learning, and memory are involved in the etiology of alcohol dependence. Systematic promotion and maintenance of motivation is a lifetime challenge in the treatment of alcohol use disorders. The second step of treatment management is the discontinuation of alcohol consumption. Withdrawal symptoms can be treated with gamma-aminobutyric acidergic substances such as benzodiazepines. Long-term relapse prevention is another challenge. Multimodal treatment can include naltrexone, a non-selective opioid receptor antagonist, or acamprosate, an N-methyl-d-aspartate receptor modulator, which are first line for pharmacological treatment on the basis of recent Cochrane analyses. Due to the complexity of etiology with both psychological and neurobiological factors, future treatment management of alcoholism may include the combination of individualized disorder-specific psychotherapy and drugs acting on different neuronal pathways, on the basis of individual vulnerability. However, the question remains unsolved whether an individualized approach is feasible and how subgroups should be defined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Amato L, Minozzi S, Davoli M (2011) Efficacy and safety of pharmacological interventions for the treatment of the alcohol withdrawal syndrome. Cochrane Database Syst Rev 15(6):CD008537. doi:10.1002/14651858.CD008537.pub2

    Google Scholar 

  • Anton RF, Moak DH, Waid LR, Latham PK, Malcolm RJ, Dias JK (1999) Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry 11:1758–1764

    Google Scholar 

  • Anton RF, O’Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A, COMBINE Study Research Group (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 17:2003–2017. doi:295/17/200310.1001/jama.295.17.2003

    Article  Google Scholar 

  • Anton RF, Oroszi G, O’Malley S, Couper D, Swift R, Pettinati H, Goldman D (2008) An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry 2:135–144. doi:10.1001/archpsyc.65.2.135

    Article  Google Scholar 

  • Arias A, Feinn R, Kranzler HR (2006) Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis. Drug Alcohol Depend 3:262–268. doi:10.1016/j.drugalcdep.2005.11.024

    Article  CAS  Google Scholar 

  • Bart G, Heilig M, LaForge KS, Pollak L, Leal SM, Ott J, Kreek MJ (2004) Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden. Mol Psychiatry 6:547–549. doi:10.1038/sj.mp.40015044001504

    Article  CAS  Google Scholar 

  • Bart G, Kreek MJ, Ott J, LaForge KS, Proudnikov D, Pollak L, Heilig M (2005) Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden. Neuropsychopharmacology 2:417–422. doi:10.1038/sj.npp.1300598

    Article  CAS  Google Scholar 

  • Benjamin D, Grant ER, Pohorecky LA (1993) Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats. Brain Res 1:137–140

    Article  Google Scholar 

  • Bergen AW, Kokoszka J, Peterson R, Long JC, Virkkunen M, Linnoila M, Goldman D (1997) Mu opioid receptor gene variants: lack of association with alcohol dependence. Mol Psychiatry 6:490–494

    Article  Google Scholar 

  • Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Jagadeeswaran P, Nogami H, Briggs AH, Cohn JB (1990) Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA 15:2055–2060

    Article  Google Scholar 

  • Boileau I, Assaad JM, Pihl RO, Benkelfat C, Leyton M, Diksic M, Tremblay RE, Dagher A (2003) Alcohol promotes dopamine release in the human nucleus accumbens. Synapse 4:226–231. doi:10.1002/syn.10226

    Article  CAS  Google Scholar 

  • Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L, Gong J, Schluger J, Strong JA, Leal SM, Tischfield JA, Kreek MJ, Yu L (1998) Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA 16:9608–9613

    Article  Google Scholar 

  • Boning J (2009) Addiction memory as a specific, individually learned memory imprint. Pharmacopsychiatry 42(Suppl 1):S66–S68. doi:10.1055/s-0029-1216357

    Article  PubMed  Google Scholar 

  • Bradley KA, Badrinath S, Bush K, Boyd-Wickizer J, Anawalt B (1998) Medical risks for women who drink alcohol. J Gen Intern Med 13:627–639

    Article  PubMed  CAS  Google Scholar 

  • Cloninger CR (1987) Neurogenetic adaptive mechanisms in alcoholism. Science 4800:410–416

    Article  Google Scholar 

  • Conway KP, Compton W, Stinson FS, Grant BF (2006) Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2:247–257

    Article  Google Scholar 

  • Covault J, Gelernter J, Hesselbrock V, Nellissery M, Kranzler HR (2004) Allelic and haplotypic association of GABRA2 with alcohol dependence. Am J Med Genet B Neuropsychiatr Genet 1:104–109. doi:10.1002/ajmg.b.30091

    Article  Google Scholar 

  • Dahchour A, De Witte P, Bolo N, Nedelec JF, Muzet M, Durbin P, Macher JP (1998) Central effects of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats. Psychiatry Res 2:107–114

    Google Scholar 

  • Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 14:5274–5278

    Article  Google Scholar 

  • Dick DM, Aliev F, Wang JC, Grucza RA, Schuckit M, Kuperman S, Kramer J, Hinrichs A, Bertelsen S, Budde JP, Hesselbrock V, Porjesz B, Edenberg HJ, Bierut LJ, Goate A (2008) Using dimensional models of externalizing psychopathology to aid in gene identification. Arch Gen Psychiatry 3:310–318

    Article  Google Scholar 

  • Drgon T, D’Addario C, Uhl GR (2006) Linkage disequilibrium, haplotype and association studies of a chromosome 4 GABA receptor gene cluster: candidate gene variants for addictions. Am J Med Genet B Neuropsychiatr Genet 8:854–860. doi:10.1002/ajmg.b.30349

    Google Scholar 

  • Du Y, Nie Y, Li Y, Wan YJ (2011) The association between the SLC6A3 VNTR 9-repeat allele and alcoholism—a meta-analysis. Alcohol Clin Exp Res 9:1625–1634. doi:10.1111/j.1530-0277.2011.01509.x

    Google Scholar 

  • Edenberg HJ, Dick DM, Xuei X, Tian H, Almasy L, Bauer LO, Crowe RR, Goate A, Hesselbrock V, Jones K, Kwon J, Li TK, Nurnberger JI Jr, O’Connor SJ, Reich T, Rice J, Schuckit MA, Porjesz B, Foroud T, Begleiter H (2004) Variations in GABRA2, encoding the alpha 2 subunit of the GABA(A) receptor, are associated with alcohol dependence and with brain oscillations. Am J Hum Genet 4:705–714. doi:10.1086/383283S0002-9297(07)61895-3

    Article  Google Scholar 

  • Enoch MA, Hodgkinson CA, Yuan Q, Albaugh B, Virkkunen M, Goldman D (2009) GABRG1 and GABRA2 as independent predictors for alcoholism in two populations. Neuropsychopharmacology 5:1245–1254

    Article  CAS  Google Scholar 

  • Fehr C, Sander T, Tadic A, Lenzen KP, Anghelescu I, Klawe C, Dahmen N, Schmidt LG, Szegedi A (2006) Confirmation of association of the GABRA2 gene with alcohol dependence by subtype-specific analysis. Psychiatr Genet 1:9–17

    Article  Google Scholar 

  • Feinn R, Nellissery M, Kranzler HR (2005) Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence. Am J Med Genet B Neuropsychiatr Genet 1:79–84. doi:10.1002/ajmg.b.30132

    Google Scholar 

  • Foroud T, Edenberg HJ, Goate A, Rice J, Flury L, Koller DL, Bierut LJ, Conneally PM, Nurnberger JI, Bucholz KK, Li TK, Hesselbrock V, Crowe R, Schuckit M, Porjesz B, Begleiter H, Reich T (2000) Alcoholism susceptibility loci: confirmation studies in a replicate sample and further mapping. Alcohol Clin Exp Res 7:933–945

    Article  Google Scholar 

  • Foroud T, Wetherill LF, Dick DM, Hesselbrock V, Nurnberger JI Jr, Kramer J, Tischfield J, Schuckit M, Bierut LJ, Xuei X, Edenberg HJ (2007) Lack of association of alcohol dependence and habitual smoking with catechol-O-methyltransferase. Alcohol Clin Exp Res 11:1773–1779. doi:10.1111/j.1530-0277.2007.00505.x

    Article  CAS  Google Scholar 

  • Gelernter J, Gueorguieva R, Kranzler HR, Zhang H, Cramer J, Rosenheck R, Krystal JH (2007) Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study. Alcohol Clin Exp Res 4:555–563. doi:10.1111/j.1530-0277.2007.00339.x

    Google Scholar 

  • George SR, Cheng R, Nguyen T, Israel Y, O’Dowd BF (1993) Polymorphisms of the D4 dopamine receptor alleles in chronic alcoholism. Biochem Biophys Res Commun 1:107–114

    Article  Google Scholar 

  • Gilman S, Koeppe RA, Adams K, Johnson-Greene D, Junck L, Kluin KJ, Brunberg J, Martorello S, Lohman M (1996) Positron emission tomographic studies of cerebral benzodiazepine-receptor binding in chronic alcoholics. Ann Neurol 2:163–171. doi:10.1002/ana.410400207

    Article  Google Scholar 

  • Gilman JM, Ramchandani VA, Davis MB, Bjork JM, Hommer DW (2008) Why we like to drink: a functional magnetic resonance imaging study of the rewarding and anxiolytic effects of alcohol. J Neurosci 18:4583–4591. doi:10.1523/JNEUROSCI.0086-08.2008

    Article  CAS  Google Scholar 

  • Glynn RJ, LoCastro JS, Hermos JA, Bosse R (1983) Social contexts and motives for drinking in men. J Stud Alcohol 6:1011–1025

    Google Scholar 

  • Grant BF, Hasin DS, Stinson FS, Dawson DA, Patricia Chou S, June Ruan W, Huang B (2005) Co-occurrence of 12-month mood and anxiety disorders and personality disorders in the US: results from the national epidemiologic survey on alcohol and related conditions. J Psychiatr Res 1:1–9. doi:10.1016/j.jpsychires.2004.05.004

    Article  Google Scholar 

  • Greenfield SF (2002) Women and alcohol use disorders. Harv Rev Psychiatry 2:76–85

    Article  Google Scholar 

  • Heilig M, Goldman D, Berrettini W, O’Brien CP (2011) Pharmacogenetic approaches to the treatment of alcohol addiction. Nat Rev Neurosci 11:670–684. doi:10.1038/nrn3110nrn3110

    Article  CAS  Google Scholar 

  • Heinz A, Sander T, Harms H, Finckh U, Kuhn S, Dufeu P, Dettling M, Gräf K, Rolfs A, Rommelspacher H, Schmidt LG (1996) Lack of allelic association of dopamine D1 and D2 (TaqIA) receptor gene polymorphisms with reduced dopaminergic sensitivity to alcoholism. Alcohol Clin Exp Res 6:1109–1113

    Article  Google Scholar 

  • Heyne A, May T, Goll P, Wolffgramm J (2000) Persisting consequences of drug intake: towards a memory of addiction. J Neural Transm 6:613–638

    Article  Google Scholar 

  • Higuchi S, Matsushita S, Muramatsu T, Murayama M, Hayashida M (1996) Alcohol and aldehyde dehydrogenase genotypes and drinking behavior in Japanese. Alcohol Clin Exp Res 3:493–497

    Article  Google Scholar 

  • Hutchison KE, McGeary J, Smolen A, Bryan A, Swift RM (2002) The DRD4 VNTR polymorphism moderates craving after alcohol consumption. Health Psychol 2:139–146

    Article  Google Scholar 

  • Hyytia P, Sinclair JD (1993) Responding for oral ethanol after naloxone treatment by alcohol-preferring AA rats. Alcohol Clin Exp Res 3:631–636

    Article  Google Scholar 

  • Institute of Medicine (1990) Broadening the base of treatment for alcohol problems. National Academy Press, Washington

    Google Scholar 

  • Johnson SW, North RA (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 2:483–488

    Google Scholar 

  • Johnson BA, Roache JD, Javors MA, DiClemente CC, Cloninger CR, Prihoda T, Bordnick PS, Ait-Daoud N, Hensler J (2000) Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: a randomized controlled trial. JAMA 8:963–971

    Article  Google Scholar 

  • Johnson BA, Roache JD, Ait-Daoud N, Zanca NA, Velazquez M (2002) Ondansetron reduces the craving of biologically predisposed alcoholics. Psychopharmacology 4:408–413. doi:10.1007/s00213-002-1002-9

    Article  CAS  Google Scholar 

  • Johnson BA, Ait-Daoud N, Ma JZ, Wang Y (2003) Ondansetron reduces mood disturbance among biologically predisposed, alcohol-dependent individuals. Alcohol Clin Exp Res 11:1773–1779. doi:10.1097/01.ALC.0000095635.46911.5D

    Article  CAS  Google Scholar 

  • Jorgensen CH, Pedersen B, Tonnese H (2011) The efficacy of disulfiram for the treatment of alcohol use disorder. Alcohol Clin Exp Res 10:1749–1758. doi:10.1111/j.1530-0277.2011.01523.x

    Article  CAS  Google Scholar 

  • Kamens HM, Andersen J, Picciotto MR (2010) The nicotinic acetylcholine receptor partial agonist varenicline increases the ataxic and sedative-hypnotic effects of acute ethanol administration in C57BL/6J mice. Alcohol Clin Exp Res 12:2053–2060. doi:10.1111/j.1530-0277.2010.01301.x

    Article  CAS  Google Scholar 

  • Kendler KS, Prescott CA, Neale MC, Pedersen NL (1997) Temperance board registration for alcohol abuse in a national sample of Swedish male twins, born 1902 to 1949. Arch Gen Psychiatry 2:178–184

    Article  Google Scholar 

  • Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 6:593–602

    Article  Google Scholar 

  • Keyes KM, Grant BF, Hasin DS (2008) Evidence for a closing gender gap in alcohol use, abuse, and dependence in the United States population. Drug Alcohol Depen 1–2:21–29. doi:10.1016/j.drugalcdep.2007.08.017

    Article  Google Scholar 

  • Kiefer F, Jahn H, Tarnaske T, Helwig H, Briken P, Holzbach R, Kämpf P, Stracke R, Baehr M, Naber D, Wiedemann K (2003) Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch Gen Psychiatry 1:92–99

    Article  Google Scholar 

  • Konishi T, Luo HR, Calvillo M, Mayo MS, Lin KM, Wan YJ (2004) ADH1B*1, ADH1C*2, DRD2 (-141C Ins), and 5-HTTLPR are associated with alcoholism in Mexican American men living in Los Angeles. Alcohol Clin Exp Res 8:1145–1152

    Article  Google Scholar 

  • Kroslak T, Laforge KS, Gianotti RJ, Ho A, Nielsen DA, Kreek MJ (2007) The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor. J Neurochem 1:77–87. doi:10.1111/j.1471-4159.2007.04738.x

    Google Scholar 

  • Krystal JH, Petrakis IL, Mason G, Trevisan L, D’Souza DC (2003) N-methyl-d-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability. Pharmacol Ther 1:79–94

    Article  CAS  Google Scholar 

  • Kuzmin A, Sandin J, Terenius L, Ogren SO (2003) Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: effects of opioid receptor-like 1 receptor agonists and naloxone. J Pharmacol Exp Ther 1:310–318. doi:10.1124/jpet.102.041350

    Article  CAS  Google Scholar 

  • Lappalainen J, Krupitsky E, Remizov M, Pchelina S, Taraskina A, Zvartau E, Somberg LK, Covault J, Kranzler HR, Krystal JH, Gelernter J (2005) Association between alcoholism and gamma-amino butyric acid alpha2 receptor subtype in a Russian population. Alcohol Clin Exp Res 4:493–498

    Article  Google Scholar 

  • Lesch KP (2005) Alcohol dependence and gene × environment interaction in emotion regulation: is serotonin the link? Eur J Pharmacol 1–3:113–124. doi:10.1016/j.ejphar.2005.09.027

    Article  CAS  Google Scholar 

  • Lesch KP, Timmesfeld N, Renner TJ, Halperin R, Roser C, Nguyen TT, Craig DW, Romanos J, Heine M, Meyer J, Freitag C, Warnke A, Romanos M, Schäfer H, Walitza S, Reif A, Stephan DA, Jacob C (2008) Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm 11:1573–1585. doi:10.1007/s00702-008-0119-3

    Article  CAS  Google Scholar 

  • Li D, Zhao H, Gelernter J (2011) Strong association of the alcohol dehydrogenase 1B gene (ADH1B) with alcohol dependence and alcohol-induced medical diseases. Biol Psychiatry 6:504–512. doi:10.1016/j.biopsych.2011.02.024

    Article  CAS  Google Scholar 

  • Littleton JM (2007) Acamprosate in alcohol dependence: implications of a unique mechanism of action. J Addict Med 3:115–125

    Article  Google Scholar 

  • Long JC, Knowler WC, Hanson RL, Robin RW, Urbanek M, Moore E, Bennett PH, Goldman D (1998) Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population. Am J Med Genet 3:216–221. doi:10.1002/(SICI)1096-8628(19980508)81:3<216:AID-AJMG2>3.0.CO;2-U

    Article  Google Scholar 

  • Luczak SE, Glatt SJ, Wall TL (2006) Meta-analyses of ALDH2 and ADH1B with alcohol dependence in Asians. Psychol Bull 4:607–621. doi:10.1037/0033-2909.132.4.607

    Article  Google Scholar 

  • Luo X, Kranzler HR, Zuo L, Wang S, Blumberg HP, Gelernter J (2005) CHRM2 gene predisposes to alcohol dependence, drug dependence and affective disorders: results from an extended case–control structured association study. Hum Mol Genet 16:2421–2434. doi:10.1093/hmg/ddi244

    Article  CAS  Google Scholar 

  • Mann K, Hermann D (2010) Individualised treatment in alcohol-dependent patients. Eur Arch Psychiatry Clin Neurosci Suppl 2:16–120. doi:10.1007/s00406-010-0153-7

    Google Scholar 

  • Matthews AG, Hoffman EK, Zezza N, Stiffler S, Hill SY (2007) The role of the GABRA2 polymorphism in multiplex alcohol dependence families with minimal comorbidity: within-family association and linkage analyses. J Stud Alcohol Drugs 5:625–633

    Google Scholar 

  • Mello NK (1972) Behavioural studies of alcoholism. Plenum Press, New York

    Google Scholar 

  • Miller WR, Rollnick S (2002) Motivational interviewing: preparing people for change, 2nd edn. Guilford Press, New York

    Google Scholar 

  • Muller CP, Schumann G (2011) Drugs as instruments: a new framework for non-addictive psychoactive drug use. Behav Brain Sci 6:293–310. doi:10.1017/S0140525X11000057

    Article  Google Scholar 

  • Mulligan CJ, Robin RW, Osier MV, Sambuughin N, Goldfarb LG, Kittles RA, Hesselbrock D, Goldman D, Long JC (2003) Allelic variation at alcohol metabolism genes (ADH1B, ADH1C, ALDH2) and alcohol dependence in an American Indian population. Hum Genet 4:325–336. doi:10.1007/s00439-003-0971-z

    Article  CAS  Google Scholar 

  • Nakamura T, Matsushita S, Nishiguchi N, Kimura M, Yoshino A, Higuchi S (1999) Association of a polymorphism of the 5HT2A receptor gene promoter region with alcohol dependence. Mol Psychiatry 1:85–88

    Article  Google Scholar 

  • O’Malley PM, Johnston LD (2002) Epidemiology of alcohol and other drug use among American college students. J Stud Alcohol Suppl 14:23–39

    PubMed  Google Scholar 

  • Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR, O’Brien CP (2003) A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 8:1546–1552. doi:10.1038/sj.npp.13002191300219

    Article  CAS  Google Scholar 

  • Parsian A, Chakraverty S, Fisher L, Cloninger CR (1997) No association between polymorphisms in the human dopamine D3 and D4 receptors genes and alcoholism. Am J Med Genet 3:281–285. doi:10.1002/(SICI)1096-8628(19970531)74:3<281:AID-AJMG8>3.0.CO;2-T

    Article  Google Scholar 

  • Pinnaduwage D, Briollais L (2005) Comparison of genotype- and haplotype-based approaches for fine-mapping of alcohol dependence using COGA data. BMC Genet 6(Suppl 1):65. doi:10.1186/1471-2156-6-S1-S65

    Article  CAS  Google Scholar 

  • Prochaska JO, DiClemente CC (1982) Trans-theoretical therapy—toward a more integrative model of change. Psychotherapy: theory. Res Prac 3:276–288

    Google Scholar 

  • Rao PS, Sari Y (2012) Glutamate transporter 1: target for the treatment of alcohol dependence. Curr Med Chem. [Epub ahead of print]

  • Ray LA, Hutchison KE (2004) A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcohol Clin Exp Res 12:1789–1795

    Article  Google Scholar 

  • Ray LA, Hutchison KE (2007) Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Arch Gen Psychiatry 9:1069–1077. doi:10.1001/archpsyc.64.9.1069

    Article  Google Scholar 

  • Reich T, Edenberg HJ, Goate A, Williams JT, Rice JP, Van Eerdewegh P, Foroud T, Hesselbrock V, Schuckit MA, Bucholz K, Porjesz B, Li TK, Conneally PM, Nurnberger JI Jr, Tischfield JA, Crowe RR, Cloninger CR, Wu W, Shears S, Carr K, Crose C, Willig C, Begleiter H (1998) Genome-wide search for genes affecting the risk for alcohol dependence. Am J Med Genet 3:207–215. doi:10.1002/(SICI)1096-8628(19980508)81:3<207:AID-AJMG1>3.0.CO;2-T

    Article  Google Scholar 

  • Reid LD, Hunter GA (1984) Morphine and naloxone modulate intake of ethanol. Alcohol 1:33–37

    Article  PubMed  CAS  Google Scholar 

  • Rollema H, Hajos M, Seymour PA, Kozak R, Majchrzak MJ, Guanowsky V, Horner WE, Chapin DS, Hoffmann WE, Johnson DE, McLean S, Freeman J, Williams KE (2009) Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition. Biochem Pharmacol 7:813–824. doi:10.1016/j.bcp.2009.05.033

    Article  CAS  Google Scholar 

  • Rosenthal RN, Gage A, Perhach JL, Goodman AM (2008) Acamprosate: safety and tolerability in the treatment of alcohol dependence. Addict Med 2:40–50

    Article  CAS  Google Scholar 

  • Rosner S, Hackl-Herrwerth A, Leucht S, Lehert P, Vecchi S, Soyka M (2010a) Acamprosate for alcohol dependence. Cochrane Database Syst Rev 8(9):CD004332. doi:10.1002/14651858.CD004332.pub2

    Google Scholar 

  • Rosner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M (2010b) Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev 8(12):CD001867. doi:10.1002/14651858.CD001867.pub2

    Google Scholar 

  • Rubak S, Sandbaek A, Lauritzen T, Christensen B (2005) Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract 513:305–312

    Google Scholar 

  • Sanders AR, Duan J, Gejman PV (2002) DNA variation and psychopharmacology of the human serotonin receptor 1B (HTR1B) gene. Pharmacogenomics 6:745–762. doi:10.1517/14622416.3.6.745

    Article  Google Scholar 

  • Smith L, Watson M, Gates S, Ball D, Foxcroft D (2008) Meta-analysis of the association of the Taq1A polymorphism with the risk of alcohol dependency: a HuGE gene–disease association review. Am J Epidemiol 2:125–138. doi:10.1093/aje/kwm281

    Google Scholar 

  • Soderpalm B, Ericson M (2011) Neurocircuitry involved in the development of alcohol addiction: the dopamine system and its access points. Curr Top Behav Neurosci. doi:10.1007/7854_2011_170

    Google Scholar 

  • Soyka M, Preuss UW, Hesselbrock V, Zill P, Koller G, Bondy B (2008) GABA-A2 receptor subunit gene (GABRA2) polymorphisms and risk for alcohol dependence. J Psychiatr Res 3:184–191. doi:10.1016/j.jpsychires.2006.11.006

    Article  Google Scholar 

  • Spanagel R (2009) Alcoholism: a systems approach from molecular physiology to addictive behavior. Physiol Rev 2:649–705. doi:10.1152/physrev.00013.2008

    Article  CAS  Google Scholar 

  • Spanagel R, Herz A, Shippenberg TS (1992) Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA 6:2046–2050

    Article  Google Scholar 

  • Spanagel R, Putzke J, Stefferl A, Schobitz B, Zieglgansberger W (1996) Acamprosate and alcohol: II. Effects on alcohol withdrawal in the rat. Eur J Pharmacol 305(1–3):45–50

    Article  PubMed  CAS  Google Scholar 

  • Stinson FS, Grant BF, Dawson DA, Ruan WJ, Huang B, Saha T (2005) Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend 1:105–116. doi:10.1016/j.drugalcdep.2005.03.009

    Article  Google Scholar 

  • Tiihonen J, Hallikainen T, Lachman H, Saito T, Volavka J, Kauhanen J, Salonen JT, Ryynänen OP, Koulu M, Karvonen MK, Pohjalainen T, Syvälahti E, Hietala J (1999) Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism. Mol Psychiatry 3:286–289

    Article  Google Scholar 

  • Tsai G, Gastfriend DR, Coyle JT (1995) The glutamatergic basis of human alcoholism. Am J Psychiatry 3:332–340

    Google Scholar 

  • Verheul R, van den Brink W, Geerlings P (1999) A three-pathway psychobiological model of craving for alcohol. Alcohol Alcohol 2:197–222

    Google Scholar 

  • Vollstadt-Klein S, Loeber S, Kirsch M, Bach P, Richter A, Buhler M, Kiefer F (2011) Effects of cue-exposure treatment on neural cue reactivity in alcohol dependence: a randomized trial. Biol Psychiatry 11:1060–1066. doi:10.1016/j.biopsych.2010.12.016

    Article  Google Scholar 

  • Wang T, Franke P, Neidt H, Cichon S, Knapp M, Lichtermann D, Maier W, Propping P, Nothen MM (2001) Association study of the low-activity allele of catechol-O-methyltransferase and alcoholism using a family-based approach. Mol Psychiatry 1:109–111

    Article  Google Scholar 

  • Wang JC, Hinrichs AL, Stock H, Budde J, Allen R, Bertelsen S, Kwon JM, Wu W, Dick DM, Rice J, Jones K, Nurnberger JI Jr, Tischfield J, Porjesz B, Edenberg HJ, Hesselbrock V, Crowe R, Schuckit M, Begleiter H, Reich T, Goate AM, Bierut LJ (2004) Evidence of common and specific genetic effects: association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome. Hum Mol Genet 17:1903–1911. doi:10.1093/hmg/ddh194ddh194

    Article  Google Scholar 

  • Whiteside U, Cronce JM, Pedersen ER, Larimer ME (2010) Brief motivational feedback for college students and adolescents: a harm reduction approach. J Clin Psychol 2:150–163

    Google Scholar 

  • Whitfield JB (2002) Alcohol dehydrogenase and alcohol dependence: variation in genotype-associated risk between populations. Am J Hum Genet 5:1247–1250. doi:10.1086/344287

    Article  Google Scholar 

  • Wiesbeck GA, Weijers HG, Wodarz N, Lesch OM, Glaser T, Boening J (2003) Gender-related differences in pharmacological relapse prevention with flupenthixol decanoate in detoxified alcoholics. Arch Womens Ment Health 4:259–262. doi:10.1007/s00737-003-0010-z

    Article  Google Scholar 

  • Williams SH (2005) Medications for treating alcohol dependence. Am Fam Physician 9:1775–1780

    Google Scholar 

  • Wolwer W, Frommann N, Janner M, Franke PE, Scherbaum N, Lieb B, Falkai P, Wobrock T, Kuhlmann T, Radermacher M, Maier W, Schütz C, Ohmann C, Burtscheidt W, Gaebel W (2011) The effects of combined acamprosate and integrative behaviour therapy in the outpatient treatment of alcohol dependence: a randomized controlled trial. Drug Alcohol Depend 2–3:417–422. doi:10.1016/j.drugalcdep.2011.05.001

    Article  CAS  Google Scholar 

  • Trial watch: Nalmefene reduces alcohol use in phase III trial (2011) Nat Rev Drug Discov 10(8):566. doi: 10.1038/nrd3518nrd3518

  • Zhang M, Kelley AE (2002) Intake of saccharin, salt, and ethanol solutions is increased by infusion of a mu opioid agonist into the nucleus accumbens. Psychopharmacology 4:415–423. doi:10.1007/s00213-001-0932-y

    Article  CAS  Google Scholar 

  • Zhang Y, Wang D, Johnson AD, Papp AC, Sadee W (2005) Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem 38:32618–32624. doi:10.1074/jbc.M504942200

    Article  CAS  Google Scholar 

  • Zinberg NE, Jacobson RC (1976) The natural history of “chipping”. Am J Psychiatry 1:37–40

    Google Scholar 

  • Zintzaras E, Stefanidis I, Santos M, Vidal F (2006) Do alcohol-metabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease? Hepatology 2:352–361. doi:10.1002/hep.21023

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Psychosomatics and Psychotherapy, University of Wuerzburg, Fuechsleinstrasse 15, 97080, Wuerzburg, Germany

    Christian Jacob

Authors
  1. Christian Jacob
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christian Jacob.

Additional information

Peter Riederer 70th birthday.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jacob, C. Peter Riederer “70th birthday” Neurobiological foundations of modern addiction treatment. J Neural Transm 120, 55–64 (2013). https://doi.org/10.1007/s00702-012-0886-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-012-0886-8

Keywords

Search

Navigation